Suppr超能文献

表皮生长因子受体构象变化的荧光素酶片段互补成像

Luciferase fragment complementation imaging of conformational changes in the epidermal growth factor receptor.

作者信息

Yang Katherine S, Ilagan Ma Xenia G, Piwnica-Worms David, Pike Linda J

机构信息

Department of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St. Louis, MO 63110, USA.

出版信息

J Biol Chem. 2009 Mar 20;284(12):7474-82. doi: 10.1074/jbc.M808041200. Epub 2009 Jan 26.

Abstract

Crystal structures of the epidermal growth factor (EGF) receptor suggest that its activation is associated with extensive conformational changes in both the extracellular and intracellular domains. However, evidence of these structural dynamics in intact cells has been lacking. Here we use luciferase complementation imaging to follow EGF-induced conformational changes in its receptor in real time in live cells. When the luciferase fragments are fused to the C terminus of an EGF receptor lacking the cytoplasmic domain, EGF stimulates a rapid increase in luciferase activity, consistent with ligand-induced receptor dimerization. However, when the luciferase fragments are fused to the C terminus of the full-length receptor, EGF induces a rapid but transient decrease in luciferase activity. The decrease requires tyrosine kinase activity, whereas the subsequent recovery requires MAP kinase activity. Our data demonstrate the utility of the luciferase system for in vivo imaging changes in EGF receptor dimerization and conformation. They also identify two sequential ligand-induced conformational changes in the EGF receptor.

摘要

表皮生长因子(EGF)受体的晶体结构表明,其激活与细胞外和细胞内结构域的广泛构象变化相关。然而,完整细胞中这些结构动力学的证据一直缺乏。在这里,我们使用荧光素酶互补成像实时追踪活细胞中EGF诱导的其受体的构象变化。当荧光素酶片段与缺乏胞质结构域的EGF受体的C末端融合时,EGF刺激荧光素酶活性迅速增加,这与配体诱导的受体二聚化一致。然而,当荧光素酶片段与全长受体的C末端融合时,EGF诱导荧光素酶活性迅速但短暂地降低。这种降低需要酪氨酸激酶活性,而随后的恢复需要丝裂原活化蛋白激酶(MAP)活性。我们的数据证明了荧光素酶系统用于体内成像EGF受体二聚化和构象变化的实用性。它们还确定了EGF受体中两种连续的配体诱导的构象变化。

相似文献

1
Luciferase fragment complementation imaging of conformational changes in the epidermal growth factor receptor.
J Biol Chem. 2009 Mar 20;284(12):7474-82. doi: 10.1074/jbc.M808041200. Epub 2009 Jan 26.
2
Mechanics of EGF receptor/ErbB2 kinase activation revealed by luciferase fragment complementation imaging.
Proc Natl Acad Sci U S A. 2012 Jan 3;109(1):137-42. doi: 10.1073/pnas.1111316109. Epub 2011 Dec 21.
5
Dynamic analysis of the epidermal growth factor (EGF) receptor-ErbB2-ErbB3 protein network by luciferase fragment complementation imaging.
J Biol Chem. 2013 Oct 18;288(42):30773-30784. doi: 10.1074/jbc.M113.489534. Epub 2013 Sep 6.
6
8
Differential activation of epidermal growth factor (EGF) receptor downstream signaling pathways by betacellulin and EGF.
Endocrinology. 2004 Sep;145(9):4232-43. doi: 10.1210/en.2004-0401. Epub 2004 Jun 10.
9
Kinase-mediated quasi-dimers of EGFR.
FASEB J. 2010 Dec;24(12):4744-55. doi: 10.1096/fj.10-166199. Epub 2010 Aug 3.
10
Quantitation of the effect of ErbB2 on epidermal growth factor receptor binding and dimerization.
J Biol Chem. 2012 Sep 7;287(37):31116-25. doi: 10.1074/jbc.M112.373647. Epub 2012 Jul 20.

引用本文的文献

1
Allosteric activation of preformed EGF receptor dimers by a single ligand binding event.
Front Endocrinol (Lausanne). 2022 Nov 30;13:1042787. doi: 10.3389/fendo.2022.1042787. eCollection 2022.
2
In-cell structural dynamics of an EGF receptor during ligand-induced dimer-oligomer transition.
Eur Biophys J. 2020 Jan;49(1):21-37. doi: 10.1007/s00249-019-01410-2. Epub 2019 Nov 18.
3
6
Identification of function-regulating antibodies targeting the receptor protein tyrosine phosphatase sigma ectodomain.
PLoS One. 2017 May 30;12(5):e0178489. doi: 10.1371/journal.pone.0178489. eCollection 2017.
7
8
Activation of transmembrane cell-surface receptors via a common mechanism? The "rotation model".
Bioessays. 2015 Sep;37(9):959-67. doi: 10.1002/bies.201500041. Epub 2015 Aug 4.
9
A structural perspective on the regulation of the epidermal growth factor receptor.
Annu Rev Biochem. 2015;84:739-64. doi: 10.1146/annurev-biochem-060614-034402. Epub 2015 Jan 26.
10
Luciferase fragment complementation imaging in preclinical cancer studies.
Oncoscience. 2014 Jun 1;1(5):310-25. doi: 10.18632/oncoscience.45. eCollection 2014.

本文引用的文献

1
ERK-dependent threonine phosphorylation of EGF receptor modulates receptor downregulation and signaling.
Cell Signal. 2008 Nov;20(11):2145-55. doi: 10.1016/j.cellsig.2008.08.006. Epub 2008 Aug 15.
2
Noninvasive imaging and quantification of epidermal growth factor receptor kinase activation in vivo.
Cancer Res. 2008 Jul 1;68(13):4990-7. doi: 10.1158/0008-5472.CAN-07-5984.
3
Heterogeneity in EGF-binding affinities arises from negative cooperativity in an aggregating system.
Proc Natl Acad Sci U S A. 2008 Jan 8;105(1):112-7. doi: 10.1073/pnas.0707080105. Epub 2007 Dec 28.
4
Oligomerization of the EGF receptor investigated by live cell fluorescence intensity distribution analysis.
Biophys J. 2007 Aug 1;93(3):1021-31. doi: 10.1529/biophysj.107.105494. Epub 2007 May 11.
6
Current state of imaging protein-protein interactions in vivo with genetically encoded reporters.
Annu Rev Biomed Eng. 2007;9:321-49. doi: 10.1146/annurev.bioeng.9.060906.152044.
7
A system for quantifying dynamic protein interactions defines a role for Herceptin in modulating ErbB2 interactions.
Proc Natl Acad Sci U S A. 2006 Dec 12;103(50):19063-8. doi: 10.1073/pnas.0605218103. Epub 2006 Dec 5.
10
EGF-ERBB signalling: towards the systems level.
Nat Rev Mol Cell Biol. 2006 Jul;7(7):505-16. doi: 10.1038/nrm1962.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验